Grandér D - Search Results

1

Proteomic screen reveals Fbw7 as a modulator of the NF-κB pathway.

Arabi A, Ullah K, Branca RM, Johansson J, Bandarra D, Haneklaus M, Fu J, Ariës I, Nilsson P, Den Boer ML, Pokrovskaja K, Grandér D, Xiao G, Rocha S, Lehtiö J, Sangfelt O. Arabi A, et al. Among authors: grander d. Nat Commun. 2012;3:976. doi: 10.1038/ncomms1975. Nat Commun. 2012. PMID: 22864569 Free PMC article.

2

MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression.

Lerner M, Lundgren J, Akhoondi S, Jahn A, Ng HF, Akbari Moqadam F, Oude Vrielink JA, Agami R, Den Boer ML, Grandér D, Sangfelt O. Lerner M, et al. Among authors: grander d. Cell Cycle. 2011 Jul 1;10(13):2172-83. doi: 10.4161/cc.10.13.16248. Epub 2011 Jul 1. Cell Cycle. 2011. PMID: 21597324

3

Mechanisms of interferon-induced cell cycle arrest.

Sangfelt O, Erickson S, Grander D. Sangfelt O, et al. Among authors: grander d. Front Biosci. 2000 Apr 1;5:D479-87. doi: 10.2741/sangfelt. Front Biosci. 2000. PMID: 10762599

4

FBXW7/hCDC4 is a general tumor suppressor in human cancer.

Akhoondi S, Sun D, von der Lehr N, Apostolidou S, Klotz K, Maljukova A, Cepeda D, Fiegl H, Dafou D, Marth C, Mueller-Holzner E, Corcoran M, Dagnell M, Nejad SZ, Nayer BN, Zali MR, Hansson J, Egyhazi S, Petersson F, Sangfelt P, Nordgren H, Grander D, Reed SI, Widschwendter M, Sangfelt O, Spruck C. Akhoondi S, et al. Among authors: grander d. Cancer Res. 2007 Oct 1;67(19):9006-12. doi: 10.1158/0008-5472.CAN-07-1320. Cancer Res. 2007. PMID: 17909001

5

Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer.

Akhoondi S, Lindström L, Widschwendter M, Corcoran M, Bergh J, Spruck C, Grandér D, Sangfelt O. Akhoondi S, et al. Among authors: grander d. Breast Cancer Res. 2010;12(6):R105. doi: 10.1186/bcr2788. Epub 2010 Dec 1. Breast Cancer Res. 2010. PMID: 21122106 Free PMC article.

6

MiR-200c regulates Noxa expression and sensitivity to proteasomal inhibitors.

Lerner M, Haneklaus M, Harada M, Grandér D. Lerner M, et al. Among authors: grander d. PLoS One. 2012;7(5):e36490. doi: 10.1371/journal.pone.0036490. Epub 2012 May 15. PLoS One. 2012. PMID: 22615771 Free PMC article.

7

Alternative signaling pathways regulating type I interferon-induced apoptosis.

Pokrovskaja K, Panaretakis T, Grandér D. Pokrovskaja K, et al. Among authors: grander d. J Interferon Cytokine Res. 2005 Dec;25(12):799-810. doi: 10.1089/jir.2005.25.799. J Interferon Cytokine Res. 2005. PMID: 16375608 Review.

8

Mechanisms of Interferon-alpha induced apoptosis in malignant cells.

Thyrell L, Erickson S, Zhivotovsky B, Pokrovskaja K, Sangfelt O, Castro J, Einhorn S, Grandér D. Thyrell L, et al. Among authors: grander d. Oncogene. 2002 Feb 14;21(8):1251-62. doi: 10.1038/sj.onc.1205179. Oncogene. 2002. PMID: 11850845

9

The HPV-16 E7 oncogene sensitizes malignant cells to IFN-alpha-induced apoptosis.

Thyrell L, Sangfelt O, Zhivotovsky B, Pokrovskaja K, Wang Y, Einhorn S, Grandér D. Thyrell L, et al. Among authors: grander d. J Interferon Cytokine Res. 2005 Feb;25(2):63-72. doi: 10.1089/jir.2005.25.63. J Interferon Cytokine Res. 2005. PMID: 15695927

10

The RBCC gene RFP2 (Leu5) encodes a novel transmembrane E3 ubiquitin ligase involved in ERAD.

Lerner M, Corcoran M, Cepeda D, Nielsen ML, Zubarev R, Pontén F, Uhlén M, Hober S, Grandér D, Sangfelt O. Lerner M, et al. Among authors: grander d. Mol Biol Cell. 2007 May;18(5):1670-82. doi: 10.1091/mbc.e06-03-0248. Epub 2007 Feb 21. Mol Biol Cell. 2007. PMID: 17314412 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

141 results

Search Page